melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.020 |
None |
0.500 |
2 |
|
1999 |
2000 |
Small cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
972
|
125
|
0.020 |
None |
0.500 |
2 |
|
2015 |
2018 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.020 |
None |
0.500 |
2 |
|
1999 |
2000 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.030 |
None |
0.667 |
3 |
2
|
2001 |
2015 |
Fibrous Dysplasia
|
disease |
|
Congenital Abnormality
|
53
|
5
|
0.040 |
None |
0.750 |
4 |
|
2017 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
0.750 |
4 |
|
2000 |
2018 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.340 |
None |
0.750 |
4 |
6
|
2001 |
2015 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.080 |
None |
0.875 |
8 |
|
2002 |
2019 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.100 |
None |
0.938 |
16 |
|
1997 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.956 |
68 |
1
|
1995 |
2020 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.100 |
None |
0.960 |
25 |
|
2008 |
2020 |
Secondary malignant neoplasm of bone
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
647
|
18
|
0.100 |
None |
0.966 |
29 |
|
2003 |
2020 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.100 |
None |
0.975 |
40 |
|
1999 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.975 |
40 |
1
|
1995 |
2020 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.100 |
None |
0.976 |
42 |
|
1999 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
0.982 |
653 |
4
|
1995 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.982 |
171 |
|
1997 |
2020 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.400 |
None |
0.983 |
634 |
4
|
1995 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.983 |
115 |
|
1997 |
2020 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
0.985 |
68 |
|
1999 |
2020 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.100 |
None |
1.000 |
52 |
|
2017 |
2020 |
Tumor-Associated Vasculature
|
disease |
|
Acquired Abnormality
|
84
|
|
0.100 |
None |
1.000 |
50 |
|
1999 |
2020 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.100 |
None |
1.000 |
47 |
|
2009 |
2020 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.400 |
None |
1.000 |
25 |
|
1997 |
2020 |